89 related articles for article (PubMed ID: 28322085)
21. Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible involvement of nitric oxide.
Babai L; Szigeti Z; Parratt JR; Végh A
Clin Sci (Lond); 2002 Apr; 102(4):435-45. PubMed ID: 11914106
[TBL] [Abstract][Full Text] [Related]
22. The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogs.
Kiss A; Juhász L; Seprényi G; Kupai K; Kaszaki J; Végh A
Br J Pharmacol; 2010 Jul; 160(5):1263-72. PubMed ID: 20590618
[TBL] [Abstract][Full Text] [Related]
23. Examination of the Changes in Calcium Homeostasis in the Delayed Antiarrhythmic Effect of Sodium Nitrite.
Demeter-Haludka V; Kovács M; Prorok J; Nagy N; Varró A; Végh Á
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766239
[TBL] [Abstract][Full Text] [Related]
24. Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase.
Kis A; Végh A; Papp J; Parratt J
Br J Pharmacol; 1999 Aug; 127(7):1545-50. PubMed ID: 10455308
[TBL] [Abstract][Full Text] [Related]
25. Effects of bisaramil on coronary-occlusion-reperfusion injury and free-radical-induced reactions.
Paróczai M; Roth E; Matos G; Temes G; Lantos J; Karpati E
Pharmacol Res; 1996 Jun; 33(6):327-36. PubMed ID: 8971954
[TBL] [Abstract][Full Text] [Related]
26. Does the opening of ATP-sensitive K+ channels modify ischaemia-induced ventricular arrhythmias in anaesthetised dogs?
Vegh A; Papp JG; György K; Kaszala K; Parratt JR
Eur J Pharmacol; 1997 Aug; 333(1):33-8. PubMed ID: 9311658
[TBL] [Abstract][Full Text] [Related]
27. Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioning.
György K; Végh A; Rastegar MA; Papp JG; Parratt JR
Cardiovasc Drugs Ther; 2000 Oct; 14(5):481-8. PubMed ID: 11101195
[TBL] [Abstract][Full Text] [Related]
28. AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.
Coker SJ; Parratt JR
Br J Pharmacol; 1985 Sep; 86(1):259-64. PubMed ID: 3840397
[TBL] [Abstract][Full Text] [Related]
29. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion.
Lefer DJ; Nakanishi K; Vinten-Johansen J
J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S34-43. PubMed ID: 7504767
[TBL] [Abstract][Full Text] [Related]
30. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
Wainwright CL; Parratt JR
Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
[TBL] [Abstract][Full Text] [Related]
31. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide.
Szigeti Z; Simon K; Parratt JR; Végh A
Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644
[TBL] [Abstract][Full Text] [Related]
32. Effects of a prophylactic or therapeutic application of perflubron emulsion on myocardial ischaemia-reperfusion injury in rats.
Rempf C; Standl T; Gottschalk A; Freitag M; Ritter A; Lang E; Tuszynski S; Burmeister MA
Eur J Anaesthesiol; 2008 Oct; 25(10):850-9. PubMed ID: 18538048
[TBL] [Abstract][Full Text] [Related]
33. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
34. N-2-mercaptopropionylglycine, a scavanger of reactive oxygen species, does not modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs.
Agnes H; Nagy L; Parratt JR; Papp J; Végh A
Cardiovasc Drugs Ther; 2004 Nov; 18(6):449-59. PubMed ID: 15770432
[TBL] [Abstract][Full Text] [Related]
35. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs.
Vegh A; Szekeres L; Parratt JR
Br J Pharmacol; 1991 Oct; 104(2):294-5. PubMed ID: 1797297
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.
Veveris M; Dambrova M; Cirule H; Meirena D; Kalvinsh I; Wikberg JE
Br J Pharmacol; 1999 Nov; 128(5):1089-97. PubMed ID: 10556947
[TBL] [Abstract][Full Text] [Related]
37. Tempol reduces reperfusion-induced arrhythmias in anaesthetized rats.
Guo R; Gao XY; Wang W; Wang HJ; Zhang F; Zhang Y; Zhu GQ
Pharmacol Res; 2005 Aug; 52(2):192-8. PubMed ID: 15967386
[TBL] [Abstract][Full Text] [Related]
38. Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium.
Rodriguez-Sinovas A; García-Dorado D; Ruiz-Meana M; Soler-Soler J
J Physiol; 2004 Aug; 559(Pt 1):245-57. PubMed ID: 15218064
[TBL] [Abstract][Full Text] [Related]
39. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
Hennan JK; Swillo RE; Morgan GA; Keith JC; Schaub RG; Smith RP; Feldman HS; Haugan K; Kantrowitz J; Wang PJ; Abu-Qare A; Butera J; Larsen BD; Crandall DL
J Pharmacol Exp Ther; 2006 Apr; 317(1):236-43. PubMed ID: 16344331
[TBL] [Abstract][Full Text] [Related]
40. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
